Piotr Wnuk, Author at - Page 11 of 14

Bristol-Myers Squibb/ Market Access/ News/ News/ News/ Novo Nordisk/ Patients/ Pfizer/ Roche/ Top stories

Pfizer backed off, but the price hike game continues

Piotr Wnuk cancer, Diabetes, Donald Trump, pricing 0 Comment

Donald Trump may have convinced the US pharma giant Pfizer to defer a price increase for dozens of

Pfizer backed off, but the price hike game continues

https://pharmaphorum.com/news/pfizer-backed-off-but-the-price-hike-game-continues/

Digital/ Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Will Babylon’s app ever speak doctors’ language?

Piotr Wnuk Babylon, Babylon Health, digital health, digital health innovation, NHS 0 Comment

Babylon Health might be one of the fastest developing digital health innovators in recent months. It is attracting

Will Babylon’s app ever speak doctors’ language?

https://pharmaphorum.com/views-and-analysis/will-babylons-app-ever-speak-doctors-language/

AstraZeneca/ News/ News/ R&D/ Top pharmaceutical companies

AZ forges surprise R&D deal with virus gene therapy biotech

Piotr Wnuk AstraZeneca, gene therapy, genetics, MedImmune 0 Comment

MedImmune, the R&D arm of AstraZeneca has teamed up with California based 4DMT, a next-generation virus-based gene therapy

AZ forges surprise R&D deal with virus gene therapy biotech

https://pharmaphorum.com/top-pharmaceutical-companies/astrazeneca/az-steps-avv-field-medimmune-4dmt/

News/ News/ Patients/ Top stories

Blood pressure drug recalled on cancer fears

Piotr Wnuk European Medicines Agency, Valsartan 0 Comment

Valsartan, a drug widely used to control blood pressure is being recalled in several countries around the world

Blood pressure drug recalled on cancer fears

https://pharmaphorum.com/news/valsartan-recalled-cancer-fears/

Market Access/ News/ News/ News/ Patients/ Pfizer/ Top pharmaceutical companies

Pfizer defers drug price hike after Trump phone call

Piotr Wnuk Donald Trump, Pfizer, President Trump, Trump 0 Comment

Pfizer has decided to defer the recent drug price increase after a long discussion with president Trump and

Pfizer defers drug price hike after Trump phone call

https://pharmaphorum.com/news/pfizer-defers-drug-price-hike-after-trump-phone-call/

News

Trump strikes Pfizer over price increases

Piotr Wnuk Donald Trump, Drug pricing, Pfizer 0 Comment

The US president took his frustration to twitter criticising Pfizer and “others” for the recent price increase and

Trump strikes Pfizer over price increases

https://pharmaphorum.com/news/trump-strikes-pfizer-over-price-increases/

Cancer/ Market Access/ News/ News/ News/ News/ Oncology/ R&D

Fotivda approved in Scotland for kidney cancer

Piotr Wnuk EUSA Pharma, kidney cancer, Oncology 0 Comment

The Scottish Medicines Consortium (SMC) has recommended regular NHS funding for EUSA Pharma’s kidney cancer drug Fotivda, enabling

Fotivda approved in Scotland for kidney cancer

https://pharmaphorum.com/news/fotivda-scotland-kidney-cancer/

R&D/ Views & Analysis/ Views and analysis

Bioprinting organs and the future of healthcare

Piotr Wnuk bioprinting, research 0 Comment

The artificial creation of human skin, tissue and internal organs may sound like something from the distant future, but

Bioprinting organs and the future of healthcare

https://pharmaphorum.com/views-and-analysis/bioprinting-organs-and-the-future-of-healthcare/

News/ News/ R&D/ Top stories

Hope for Alzheimer’s treatment after promising study results

Piotr Wnuk Alzheimer's, Alzheimer's disease, Biogen, Eisai 0 Comment

Biogen and Eisai said their latest clinical study confirmed the amyloid hypothesis and might lead to the first

Hope for Alzheimer’s treatment after promising study results

https://pharmaphorum.com/news/alzheimers-disease-promising-study/

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

Pfizer backed off, but the price hike game continues

Will Babylon’s app ever speak doctors’ language?

AZ forges surprise R&D deal with virus gene therapy biotech

Blood pressure drug recalled on cancer fears

Pfizer defers drug price hike after Trump phone call

Trump strikes Pfizer over price increases

Fotivda approved in Scotland for kidney cancer

Bioprinting organs and the future of healthcare

Hope for Alzheimer’s treatment after promising study results

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

Login